Localization and characterization of serologic epitopes on HLA-A2.

Area of Science:

• Immunology
• Molecular Biology
• Protein Chemistry

Background:

• Class I Major Histocompatibility Complex (MHC) molecules present peptides to T cells.
• Understanding HLA-A2 epitopes is vital for immune response studies and therapies.
• Monoclonal antibodies (mAbs) are key tools for defining antigen-specific regions.

Purpose of the Study:

• To identify specific regions of HLA-A2 molecules that form epitopes recognized by monoclonal antibodies (mAbs).
• To determine the contribution of individual amino acid residues to HLA-A2 serological specificities.

Main Methods:

• Generated a panel of 68 site-directed mutant HLA-A2 genes.
• Expressed variant HLA-A2 molecules in cells via DNA-mediated gene transfer.
• Analyzed the binding of 11 mAbs to variant HLA-A2 molecules.

Main Results:

• Five of 11 mAbs mapped to the alpha 1 and alpha 2 domains of HLA-A2.
• Specific epitopes were localized to the alpha 2-helix and adjacent beta-strands.
• Substitutions at conserved residues resulted in no detectable protein expression.
• Antibody binding sites were located on the molecule's surface, outside the peptide-binding cleft.

Conclusions:

• Serological specificities of HLA-A2 are determined by amino acid positions on the molecule's surface.
• The peptide-binding cleft is not the primary determinant for the epitopes recognized by the studied mAbs.
• This research refines the understanding of HLA-A2 structure-function relationships and antibody recognition.